메뉴 건너뛰기




Volumn 153, Issue 3, 2013, Pages 243-249

Tumour endothelial cells acquire drug resistance in a tumour microenvironment

Author keywords

angiogenesis; anti angiogenic therapy; drug resistance; endothelial cells; tumours

Indexed keywords

BEVACIZUMAB; CD133 ANTIGEN; ENDOGLIN; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PAZOPANIB; PROTEIN KINASE B; SORAFENIB; SUNITINIB; THY 1 ANTIGEN; UFT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VERAPAMIL;

EID: 84874336464     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs152     Document Type: Review
Times cited : (63)

References (69)
  • 1
    • 33947732977 scopus 로고    scopus 로고
    • Angiogenesis: An organizing principle for drug discovery?
    • Folkman, J. (2007) Angiogenesis: An organizing principle for drug discovery? Nat. Rev. Drug Discov. 6, 273-286
    • (2007) Nat. Rev. Drug Discov , vol.6 , pp. 273-286
    • Folkman, J.1
  • 3
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman, J. (1971) Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285, 1182-1186
    • (1971) N. Engl. J. Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 4
    • 30944446883 scopus 로고    scopus 로고
    • Lessons from phase III clinical trials on anti-VEGF therapy for cancer
    • Jain, R.K., Duda, D.G., Clark, J.W., and Loeffler, J.S. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat. Clin. Pract. Oncol. 3, 24-40
    • (2006) Nat. Clin. Pract. Oncol , vol.3 , pp. 24-40
    • Jain, R.K.1    Duda, D.G.2    Clark, J.W.3    Loeffler, J.S.4
  • 5
    • 70349782389 scopus 로고    scopus 로고
    • An overview of small-molecule inhibitors of VEGFR signaling
    • Ivy, S.P., Wick, J.Y., and Kaufman, B.M. (2009) An overview of small-molecule inhibitors of VEGFR signaling. Nat. Rev. Clin. Oncol. 6, 569-579
    • (2009) Nat. Rev. Clin. Oncol , vol.6 , pp. 569-579
    • Ivy, S.P.1    Wick, J.Y.2    Kaufman, B.M.3
  • 6
    • 2942615257 scopus 로고    scopus 로고
    • The anti-angiogenic basis of metronomic chemotherapy
    • Kerbel, R.S. and Kamen, B.A. (2004) The anti-angiogenic basis of metronomic chemotherapy. Nat. Rev. Cancer 4, 423-436
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 423-436
    • Kerbel, R.S.1    Kamen, B.A.2
  • 7
    • 0035214416 scopus 로고    scopus 로고
    • Metronomic scheduling: The future of chemotherapy?
    • Gasparini, G (2001) Metronomic scheduling: The future of chemotherapy? Lancet Oncol. 2, 733-740
    • (2001) Lancet Oncol , vol.2 , pp. 733-740
    • Gasparini, G.1
  • 8
    • 34547617338 scopus 로고    scopus 로고
    • Antiangiogenic strategies on defense: On the possibility of blocking rebounds by the tumor vasculature after chemotherapy
    • Shaked, Y. and Kerbel, R.S. (2007) Antiangiogenic strategies on defense: On the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Res. 67, 7055-7058
    • (2007) Cancer Res , vol.67 , pp. 7055-7058
    • Shaked, Y.1    Kerbel, R.S.2
  • 9
    • 0034087691 scopus 로고    scopus 로고
    • Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
    • Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D.J., Bohlen, P., and Kerbel, R.S. (2000) Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J. Clin. Invest. 105, R15-R24
    • (2000) J. Clin. Invest , vol.105
    • Klement, G.1    Baruchel, S.2    Rak, J.3    Man, S.4    Clark, K.5    Hicklin, D.J.6    Bohlen, P.7    Kerbel, R.S.8
  • 10
    • 0025717523 scopus 로고
    • Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents
    • Kerbel, R.S. (1991) Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. Bioessays 13, 31-36
    • (1991) Bioessays , vol.13 , pp. 31-36
    • Kerbel, R.S.1
  • 11
    • 77955172181 scopus 로고    scopus 로고
    • Metronomic chemotherapy: New rationale for
    • new directions
    • Pasquier, E., Kavallaris, M., and Andre, N. (2010) Metronomic chemotherapy: New rationale for new directions. Nat. Rev. Clin. Oncol. 7, 455-465
    • (2010) Nat. Rev. Clin. Oncol , vol.7 , pp. 45-465
    • Pasquier, E.1    Kavallaris, M.2    Andre, N.3
  • 13
    • 67649995780 scopus 로고    scopus 로고
    • Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer
    • Mehta, R.S., Jackson, D., and Schubbert, T. (2009) Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer. J. Clin. Oncol. 27, 3067-3068
    • (2009) J. Clin. Oncol , vol.27 , pp. 3067-3068
    • Mehta, R.S.1    Jackson, D.2    Schubbert, T.3
  • 15
    • 0035692285 scopus 로고    scopus 로고
    • Possible mechanisms of acquired resistance to anti-angiogenic drugs: Implications for the use of combination therapy approaches
    • Kerbel, R.S., Yu, J., Tran, J., Man, S., Viloria-Petit, A., Klement, G., Coomber, B.L., and Rak, J. (2001) Possible mechanisms of acquired resistance to anti-angiogenic drugs: Implications for the use of combination therapy approaches. Cancer Metastasis Rev. 20, 79-86
    • (2001) Cancer Metastasis Rev , vol.20 , pp. 79-86
    • Kerbel, R.S.1    Yu, J.2    Tran, J.3    Man, S.4    Viloria-Petit, A.5    Klement, G.6    Coomber, B.L.7    Rak, J.8
  • 17
    • 34247383919 scopus 로고    scopus 로고
    • A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma
    • Krzyzanowska, M.K., Tannock, I.F., Lockwood, G., Knox, J., Moore, M., and Bjarnason, G.A. (2007) A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma. Cancer Chemother. Pharmacol. 60, 135-141
    • (2007) Cancer Chemother. Pharmacol , vol.60 , pp. 135-141
    • Krzyzanowska, M.K.1    Tannock, I.F.2    Lockwood, G.3    Knox, J.4    Moore, M.5    Bjarnason, G.A.6
  • 18
    • 26644471951 scopus 로고    scopus 로고
    • Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
    • Casanovas, O., Hicklin, D.J., Bergers, G., and Hanahan, D. (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299-309
    • (2005) Cancer Cell , vol.8 , pp. 299-309
    • Casanovas, O.1    Hicklin, D.J.2    Bergers, G.3    Hanahan, D.4
  • 19
    • 36749052895 scopus 로고    scopus 로고
    • Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy
    • Ebos, J.M., Lee, C.R., Christensen, J.G., Mutsaers, A.J., and Kerbel, R.S. (2007) Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc. Natl Acad. Sci. U S A 104, 17069-17074
    • (2007) Proc. Natl Acad. Sci. U S A , vol.104 , pp. 17069-17074
    • Ebos, J.M.1    Lee, C.R.2    Christensen, J.G.3    Mutsaers, A.J.4    Kerbel, R.S.5
  • 21
  • 23
    • 70549102293 scopus 로고    scopus 로고
    • Drug resistance associated with antiangiogenesis therapy
    • Eikesdal, H.P. and Kalluri, R. (2009) Drug resistance associated with antiangiogenesis therapy. Semin. Cancer Biol. 19, 310-317
    • (2009) Semin. Cancer Biol , vol.19 , pp. 310-317
    • Eikesdal, H.P.1    Kalluri, R.2
  • 24
    • 0033822622 scopus 로고    scopus 로고
    • Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption
    • Rubenstein, J.L., Kim, J., Ozawa, T., Zhang, M., Westphal, M., Deen, D.F., and Shuman, M.A. (2000) Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2, 306-314
    • (2000) Neoplasia , vol.2 , pp. 306-314
    • Rubenstein, J.L.1    Kim, J.2    Ozawa, T.3    Zhang, M.4    Westphal, M.5    Deen, D.F.6    Shuman, M.A.7
  • 25
    • 0036067866 scopus 로고    scopus 로고
    • Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance
    • Döme, B., Paku, S., Somlai, B., and Tímár, J. (2002) Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J. Pathol. 197, 355-362
    • (2002) J. Pathol , vol.197 , pp. 355-362
    • Döme, B.1    Paku, S.2    Somlai, B.3    Tímár, J.4
  • 31
    • 59649129538 scopus 로고    scopus 로고
    • Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2
    • Shukla, S., Robey, R.W., Bates, S.E., and Ambudkar, S.V. (2009) Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. Drug Metab. Dispos. 37, 359-365
    • (2009) Drug Metab. Dispos , vol.37 , pp. 359-365
    • Shukla, S.1    Robey, R.W.2    Bates, S.E.3    Ambudkar, S.V.4
  • 32
    • 33745303045 scopus 로고    scopus 로고
    • Nature hypoxia signalling in cancer and approaches to enforce tumour regression
    • Pouyssëgur, J., Dayan, F., and Mazure, N.M. (2006) Nature hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443
    • (2006) Nature , vol.441 , pp. 437-443
    • Pouyssëgur, J.1    Dayan, F.2    Mazure, N.M.3
  • 34
    • 33644863498 scopus 로고    scopus 로고
    • Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF
    • Liang, W.C., Wu, X., Peale, F.V., Lee, C.V., Meng, Y.G., Gutierrez, J., Fu, L., Malik, A.K., Gerber, H.P., Ferrara, N., and Fuh, G. (2006) Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J. Biol. Chem. 281, 951-961
    • (2006) J. Biol. Chem , vol.281 , pp. 951-961
    • Liang, W.C.1    Wu, X.2    Peale, F.V.3    Lee, C.V.4    Meng, Y.G.5    Gutierrez, J.6    Fu, L.7    Malik, A.K.8    Gerber, H.P.9    Ferrara, N.10    Fuh, G.11
  • 36
    • 31044433663 scopus 로고    scopus 로고
    • Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
    • Condeelis, J. and Pollard, J.W. (2006) Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266
    • (2006) Cell 124 , pp. 263-266
    • Condeelis, J.1    Pollard, J.W.2
  • 37
    • 33747602354 scopus 로고    scopus 로고
    • Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
    • Nozawa, H., Chiu, C., and Hanahan, D. (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. U S A. 103, 12493-12498
    • (2006) Proc. Natl Acad. Sci. U S A. , vol.103 , pp. 12493-12498
    • Nozawa, H.1    Chiu, C.2    Hanahan, D.3
  • 38
    • 54449094358 scopus 로고    scopus 로고
    • Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity
    • Eikesdal, H.P., Sugimoto, H., Birrane, G., Maeshima, Y., Cooke, V.G., Kieran, M., and Kalluri, R. (2008) Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proc. Natl Acad. Sci. U S A. 105, 15040-15045
    • (2008) Proc. Natl Acad. Sci. U S A. , vol.105 , pp. 15040-15045
    • Eikesdal, H.P.1    Sugimoto, H.2    Birrane, G.3    Maeshima, Y.4    Cooke, V.G.5    Kieran, M.6    Kalluri, R.7
  • 39
    • 63049104211 scopus 로고    scopus 로고
    • Microenvironmental regulation of metastasis
    • Joyce, J.A. and Pollard, J.W. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 239-252
    • Joyce, J.A.1    Pollard, J.W.2
  • 41
    • 3142767799 scopus 로고    scopus 로고
    • Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas
    • Streubel, B., Chott, A., Huber, D., Exner, M., Jager, U., Wagner, O., and Schwarzinger, I. (2004) Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N. Engl. J. Med. 351, 250-259
    • (2004) N. Engl. J. Med , vol.351 , pp. 250-259
    • Streubel, B.1    Chott, A.2    Huber, D.3    Exner, M.4    Jager, U.5    Wagner, O.6    Schwarzinger, I.7
  • 43
    • 0038718703 scopus 로고    scopus 로고
    • Altered angiogenesis and survival in human tumor-derived endothelial cells
    • Bussolati, B., Deambrosis, I., Russo, S., Deregibus, M.C., and Camussi, G. (2003) Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J. 17, 1159-1161
    • (2003) FASEB J. , vol.17 , pp. 1159-1161
    • Bussolati, B.1    Deambrosis, I.2    Russo, S.3    Deregibus, M.C.4    Camussi, G.5
  • 44
    • 68049139572 scopus 로고    scopus 로고
    • Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells
    • Xiong, Y.Q., Sun, H.C., Zhang, W., Zhu, X.D., Zhuang, P.Y., Zhang, J.B., Wang, L., Wu, W.Z., Qin, L.X., and Tang, Z.Y. (2009) Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin. Cancer Res. 15, 4838-4846
    • (2009) Clin. Cancer Res , vol.15 , pp. 4838-4846
    • Xiong, Y.Q.1    Sun, H.C.2    Zhang, W.3    Zhu, X.D.4    Zhuang, P.Y.5    Zhang, J.B.6    Wang, L.7    Wu, W.Z.8    Qin, L.X.9    Tang, Z.Y.10
  • 46
    • 0034682892 scopus 로고    scopus 로고
    • Genes expressed in human tumor endothelium
    • St Croix, B., Rago, C., Velculescu, V. et al. (2000) Genes expressed in human tumor endothelium. Science 289, 1197-1202
    • (2000) Science , vol.289 , pp. 1197-1202
    • St Croix, B.1    Rago, C.2    Velculescu, V.3
  • 49
    • 16844381577 scopus 로고    scopus 로고
    • A new perspective on tumor endothelial cells: Unexpected chromosome and centrosome abnormalities
    • Hida, K. and Klagsbrun, M. (2005) A new perspective on tumor endothelial cells: Unexpected chromosome and centrosome abnormalities. Cancer Res. 65, 2507-2510
    • (2005) Cancer Res , vol.65 , pp. 2507-2510
    • Hida, K.1    Klagsbrun, M.2
  • 50
    • 33644546368 scopus 로고    scopus 로고
    • Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors
    • Amin, D.N., Hida, K., Bielenberg, D.R., and Klagsbrun, M. (2006) Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res. 66, 2173-2180
    • (2006) Cancer Res , vol.66 , pp. 2173-2180
    • Amin, D.N.1    Hida, K.2    Bielenberg, D.R.3    Klagsbrun, M.4
  • 53
    • 33744470405 scopus 로고    scopus 로고
    • Isolation and characterization of human breast tumor-derived endothelial cells
    • Grange, C., Bussolati, B., Bruno, S., Fonsato, V., Sapino, A., and Camussi, G. (2006) Isolation and characterization of human breast tumor-derived endothelial cells. Oncol. Rep. 15, 381-386
    • (2006) Oncol. Rep , vol.15 , pp. 381-386
    • Grange, C.1    Bussolati, B.2    Bruno, S.3    Fonsato, V.4    Sapino, A.5    Camussi, G.6
  • 55
    • 0037137872 scopus 로고    scopus 로고
    • Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1
    • Janz, M., Harbeck, N., Dettmar, P., Berger, U., Schmidt, A., Jurchott, K., Schmitt, M., and Royer, H.D. (2002) Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int. J. Cancer 97, 278-282
    • (2002) Int. J. Cancer , vol.97 , pp. 278-282
    • Janz, M.1    Harbeck, N.2    Dettmar, P.3    Berger, U.4    Schmidt, A.5    Jurchott, K.6    Schmitt, M.7    Royer, H.D.8
  • 57
    • 1942477310 scopus 로고    scopus 로고
    • Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer
    • Huang, X., Ushijima, K., Komai, K., Takemoto, Y., Motoshima, S., Kamura, T., and Kohno, K. (2004) Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Gynecol. Oncol. 93, 287-291
    • (2004) Gynecol. Oncol , vol.93 , pp. 287-291
    • Huang, X.1    Ushijima, K.2    Komai, K.3    Takemoto, Y.4    Motoshima, S.5    Kamura, T.6    Kohno, K.7
  • 58
    • 0026669192 scopus 로고
    • Functional involvement of P-glycoprotein in blood-brain barrier
    • Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., and Tsuruo, T. (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267, 20383-20391
    • (1992) J. Biol. Chem , vol.267 , pp. 20383-20391
    • Tatsuta, T.1    Naito, M.2    Oh-hara, T.3    Sugawara, I.4    Tsuruo, T.5
  • 59
    • 0037648896 scopus 로고    scopus 로고
    • Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal
    • Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., and Haga, N. (2003) Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal. Cancer Sci. 94, 15-21
    • (2003) Cancer Sci , vol.94 , pp. 15-21
    • Tsuruo, T.1    Naito, M.2    Tomida, A.3    Fujita, N.4    Mashima, T.5    Sakamoto, H.6    Haga, N.7
  • 60
    • 84857040086 scopus 로고    scopus 로고
    • Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels
    • Naito, H., Kidoya, H., Sakimoto, S., Wakabayashi, T., and Takakura, N. (2011) Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels. EMBO J. 31, 842-855
    • (2011) EMBO J. , vol.31 , pp. 842-855
    • Naito, H.1    Kidoya, H.2    Sakimoto, S.3    Wakabayashi, T.4    Takakura, N.5
  • 63
    • 4043181214 scopus 로고    scopus 로고
    • Cancer genes and the pathways they control
    • Vogelstein, B. and Kinzler, K.W. (2004) Cancer genes and the pathways they control. Nat. Med. 10, 789-799
    • (2004) Nat. Med , vol.10 , pp. 789-799
    • Vogelstein, B.1    Kinzler, K.W.2
  • 64
    • 34047245311 scopus 로고    scopus 로고
    • Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1
    • Alavi, A.S., Acevedo, L., Min, W., and Cheresh, D.A. (2007) Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1. Cancer Res. 67, 2766-2772
    • (2007) Cancer Res , vol.67 , pp. 2766-2772
    • Alavi, A.S.1    Acevedo, L.2    Min, W.3    Cheresh, D.A.4
  • 65
    • 33750702508 scopus 로고    scopus 로고
    • LY294002, a specific inhibitor of PI3K/ Akt kinase pathway, antagonizes P-glycoproteinmediated multidrug resistance
    • Barancik, M., Bohacova, V., Sedlak, J., Sulova, Z., and Breier, A. (2006) LY294,002, a specific inhibitor of PI3K/ Akt kinase pathway, antagonizes P-glycoproteinmediated multidrug resistance. Eur. J. Pharm. Sci. 29, 426-434
    • (2006) Eur. J. Pharm. Sci , vol.29 , pp. 426-434
    • Barancik, M.1    Bohacova, V.2    Sedlak, J.3    Sulova, Z.4    Breier, A.5
  • 66
    • 66849111843 scopus 로고    scopus 로고
    • Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells
    • Zhang, Y., Qu, X., Hu, X., Yang, X., Hou, K., Teng, Y., Zhang, J., Sada, K., and Liu, Y. (2009) Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells. J. Pathol. 218, 248-255
    • (2009) J. Pathol , vol.218 , pp. 248-255
    • Zhang, Y.1    Qu, X.2    Hu, X.3    Yang, X.4    Hou, K.5    Teng, Y.6    Zhang, J.7    Sada, K.8    Liu, Y.9
  • 68
    • 70349609377 scopus 로고    scopus 로고
    • Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells
    • Ohga, N., Hida, K., Hida, Y., Muraki, C., Tsuchiya, K., Matsuda, K., Ohiro, Y., Totsuka, Y., and Shindoh, M. (2009) Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells. Cancer Sci. 100, 1963-1970
    • (2009) Cancer Sci , vol.100 , pp. 1963-1970
    • Ohga, N.1    Hida, K.2    Hida, Y.3    Muraki, C.4    Tsuchiya, K.5    Matsuda, K.6    Ohiro, Y.7    Totsuka, Y.8    Shindoh, M.9
  • 69
    • 11844254414 scopus 로고    scopus 로고
    • Normalization of tumor vasculature:an emerging concept in antiangiogenic therapy
    • Jain, R.K. (2005) Normalization of tumor vasculature:an emerging concept in antiangiogenic therapy. Science 58-62
    • (2005) Science , pp. 58-62
    • Jain, R.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.